Watch the latest episode of focusIR Fireside Chats: Why Edinburgh Investment Trust Is Backing Turnaround Stocks for 2026 Growth. View here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksDX..L Regulatory News (DX.)

  • There is currently no data for DX.

Form 8.3 - DX (Group) plc

25 Jan 2024 14:12

RNS Number : 9547A
Barclays PLC
25 January 2024

FORM 8.3

PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY

A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR

MORE

Rule 8.3 of the Takeover Code (the "Code")

1.

KEY INFORMATION

(a)

Full name of discloser:

Barclays PLC.

(b)

Owner or controller of interest and short

positions disclosed, if different from 1(a):

(c)

Name of offeror/offeree in relation to whose

DX GROUP PLC

relevant securities this form relates:

(d)

If an exempt fund manager connected with an

offeror/offeree, state this and specify identity of

offeror/offeree:

(e)

Date position held/dealing undertaken:

24 Jan 2024

(f)

In addition to the company in 1(c) above, is the discloser making

NO

disclosures in respect of any other party to the offer?

2.

POSITIONS OF THE PERSON MAKING THE DISCLOSURE

(a)

Interests and short positions in the relevant securities of the offeror or offeree

to which the disclosure relates following the dealing(if any)

Class of relevant security:

1p ordinary

Interests

Short Positions

Number

(%)

Number

(%)

(1)

Relevant securities owned

and/or controlled:

12,477,995

2.06%

0

0.00%

(2)

Cash-settled derivatives:

and/or controlled:

0

0.00%

12,477,995

2.06%

(3)

Stock-settled derivatives (including options)

and agreements to purchase/sell:

0

0.00%

0

0.00%

TOTAL:

12,477,995

2.06%

12,477,995

2.06%

(b)

Rights to subscribe for new securities (including directors and other executive

options)

Class of relevant security in relation to

which subscription right exists

Details, including nature of the rights

concerned and relevant percentages:

3.

DEALINGS (IF ANY) BY THE EXEMPT PRINCIPAL TRADER

(a)

Purchases and sales

Class of relevant

Purchase/sale

Number of

Price per unit

security

securities

1p ordinary

Purchase

1,657

0.4729 GBP

1p ordinary

Sale

1,657

0.4730 GBP

(b)

Cash-settled derivative transactions

Class of

Product

Nature of dealing

Number of

Price per

relevant

description

reference

unit

security

securities

(c)

Stock-settled derivative transactions (including options)

(i)

Writing, selling, purchasing or varying

Class

Product

Writing,

Number

Exercise

Type

Expiry

Option

of

description

purchasing,

of

price

date

money

relevant

selling,

securities

per unit

paid/

security

varying etc

to which

received

option

per unit

relates

(ii)

Exercising

Class of relevant

Product description

Exercising/ exercised against

Number of

Exercise price per

security

securities

unit

(d)

Other dealings (including subscribing for new securities)

Class of relevant

Nature of Dealings

Details

Price per unit (if

security

applicable)

4.

OTHER INFORMATION

(a)

Indemnity and other dealings arrangements

Details of any indemnity or option arrangement, or any agreement or understanding,

formal or informal, relating to relevant securities which may be an inducement to deal

or refrain from dealing entered into by the exempt principal trader making the disclosure and any party

to the offer or any person acting in concert with a party to the offer:

NONE

(b)

Agreements, arrangements or understandings relating to options or derivatives

Details of any agreement, arrangement or understanding, formal or informal, between

the person making the disclosure and any other person relating to:

(i) the voting rights of any relevant securities under any option; or

(ii) the voting rights of future acquisition or disposal of any relevant securities to which

any derivative is referenced:

NONE

(c)

Attachments

Is a Supplemental Form 8 (Open Positions) attached?

NO

Date of disclosure:

25 Jan 2024

Contact name:

Large Holdings Regulatory Operations

Telephone number:

020 3134 7213

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
END
RETMZGZMDKGGDZM
Date   Source Headline
6th Feb 20194:40 pmRNSSecond Price Monitoring Extn
6th Feb 20194:35 pmRNSPrice Monitoring Extension
4th Feb 20197:00 amRNSTrading Statement
17th Dec 20183:06 pmRNSDirector/PDMR Shareholding
4th Dec 201812:29 pmRNSResult of AGM
4th Dec 20187:00 amRNSAGM Statement
3rd Dec 20187:00 amRNSDirector Disclosure
7th Nov 201811:07 amRNSDirector Declaration
29th Oct 20184:35 pmRNSPrice Monitoring Extension
15th Oct 20187:00 amRNSNotice of AGM
2nd Oct 20183:47 pmRNSPreliminary Results - replacement
2nd Oct 20187:00 amRNSPreliminary Results
14th Aug 20184:40 pmRNSSecond Price Monitoring Extn
14th Aug 20184:35 pmRNSPrice Monitoring Extension
26th Jul 20187:00 amRNSGrant of share awards and PDMR notification
18th Jul 20187:00 amRNSTrading Update
14th Jun 20187:00 amRNSDirector/PDMR Shareholding
6th Jun 20183:02 pmRNSHolding(s) in Company
25th May 201810:50 amRNSGrant of Share Awards and PDMR Shareholding
24th May 20185:47 pmRNSHolding(s) in Company
23rd May 20188:45 amRNSCompletion of Transaction and Director Dealing
23rd May 20187:00 amRNSDirector/PDMR Shareholding
22nd May 20185:04 pmRNSTotal Voting Rights
22nd May 201811:38 amRNSResult of General Meeting
3rd May 20186:32 pmRNSFundraising and Loan Note Cancellation
29th Mar 20187:00 amRNSInterim Results
21st Mar 20187:00 amRNSAppointment of Chief Financial Officer
19th Mar 20187:00 amRNSNotice of Results
5th Feb 20183:29 pmRNSHolding(s) in Company
29th Jan 20187:00 amRNSChange of Adviser
3rd Jan 20185:15 pmRNSDirector/PDMR Shareholding
22nd Dec 20171:19 pmRNSCompletion of Loan Note issue
22nd Dec 20171:14 pmRNSDirector/PDMR Shareholding
22nd Dec 20171:13 pmRNSGrant of share awards and PDMR notification
18th Dec 201711:09 amRNSHolding(s) in Company
15th Dec 201711:41 amRNSResult of GM
8th Dec 201712:22 pmRNSResult of AGM
28th Nov 20177:00 amRNSRe: GM Notice, Circular and Incentive Awards
14th Nov 20179:00 amRNSPosting of Annual Report & Notice of AGM
27th Oct 201712:07 pmRNSSecond Price Monitoring Extn
27th Oct 201712:02 pmRNSPrice Monitoring Extension
20th Oct 201712:07 pmRNSSecond Price Monitoring Extn
20th Oct 201712:02 pmRNSPrice Monitoring Extension
20th Oct 20177:00 amRNSBoard Changes
20th Oct 20177:00 amRNSPreliminary Results
9th Oct 20177:00 amRNS£24m Fundraising, CEO Appointment & Board Changes
29th Sep 201712:21 pmRNSRe: Property Transaction
28th Sep 20177:00 amRNSMajor New Contract with IKEA
22nd Sep 20177:00 amRNSFinancing Update, Property Disposal, Gatemore Loan
20th Sep 20174:48 pmRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.